Assyro AI

FDA Orange Book · active-ingredient family

Phenylephrine hydrochloride; promethazine hydrochloride

Phenylephrine hydrochloride; promethazine hydrochloride is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PHENERGAN VC · NDA 008604

1

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · syrup

ProductApplicantApplicationTEApproved
PHENERGAN VCRLDANI PHARMSNDA 008604Apr 02, 1984

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDEHIKMAANDA 040675Dec 23, 2014
PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDEAMNEAL PHARMSANDA 040902AAAug 25, 2009
PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDEPAI HOLDINGSANDA 040654AADec 07, 2006
PHERAZINE VCHALSEYANDA 088868Mar 02, 1987
PROMETHAZINE VC PLAINCENCIANDA 088815Nov 22, 1985
PROMETHAZINE VC PLAINXTTRIUM LABS INCANDA 088897Jan 04, 1985
PROMETH VC PLAINRLDG AND W LABS INCANDA 088761Nov 08, 1984

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Phenylephrine hydrochloride; promethazine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.